BPA Call HSCECR12A00007-HSCECR13J00018

The U.S. Department of Health and Human Services (HHS) awarded a $5,099,064.36 delivery order contract to Denver Health and Hospital Authority (Denver Health) to conduct a study comparing tuberculosis skin tests (TST) and interferon-gamma release assays (IGRAs) in latent tuberculosis infection (LTBI) patients. The contract was issued under the Tuberculosis Epidemiology Studies Consortium, a larger indefinite delivery vehicle held by HHS. The award did not utilize any set-aside designations....

This is a $24,288,162 cost-reimbursement contract awarded by the U.S. Agency for International Development (USAID) to Project Hope - The People-To-People Health Foundation Inc. to implement the USAID/CAR TB Project in Tajikistan and Uzbekistan. The contract aims to provide services to ensure more effective and accessible tuberculosis (TB) diagnosis for all, including vulnerable populations, in order to reduce the burden of TB and development of drug-resistant TB in Central Asia. The contract has...

The Centers for Disease Control and Prevention (CDC) Pittsburgh division awarded a $10.67 million cost-reimbursable contract to King County's Public Health-Seattle & King County division on January 1, 2021, with a completion date of December 31, 2030. This definitive contract, awarded competitively with no set-aside designation, supports tuberculosis clinical trials and consortium services. The primary deliverables include participation in clinical research studies, adherence to study...

The Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $3.78M to Denver Health and Hospital Authority for tuberculosis trials and consortium services. The contract, effective January 1, 2021, and extending through December 31, 2030, supports clinical research activities under the CDC's broader tuberculosis prevention and treatment initiatives. Denver Health will serve as a participating site in the Tuberculosis Trials Consortium, conducting...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $146,040.00 firm fixed-price purchase order to the National Institute For Research In Tuberculosis, a non-profit organization and hospital in India. The contract is for "EARLY BATERICIDAL ACTIVITY (EBA) OF ANTI-TB DRUGS IN INDIA." The award does not have a set-aside designation. Based on the awardee's background, it appears the National Institute For Research In Tuberculosis is providing...

This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...

This is a $5,176,985.37 cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County. The contract is to develop, implement, and evaluate interventions to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The contract is part of the TBESC 3 - Seattle and King County program and does not have a...

This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Hawaii Department of Health - Children With Special Health Needs - NBS Division, a state government entity, to conduct a comparison of tuberculosis skin tests (TST) versus interferon-gamma release assays (IGRA) in patients with latent tuberculosis infection (LTBI). The $3,733,229.06 cost-no-fee contract has an ultimate completion date of September 29, 2021 and is a delivery order under the...

Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...

The Centers for Disease Control and Prevention (CDC) awarded The Research Institute of the McGill University Health Centre a $13.5M cost-plus-no-fee definitive contract on January 1, 2021, for Tuberculosis Trials Consortium Services through December 31, 2030. This ten-year engagement supports clinical research activities including tuberculosis treatment, diagnosis, and prevention trials as part of the Tuberculosis Trials Consortium. The contract was not set aside for any specific business type...